It is likely that activated mTOR is also present in some TSC skin lesions because loss of heterozygosity for TSC2 has been demonstrated in a facial angiofibroma [33] and tuberin and/or hamartin are absent in many facial angiofibromas from individuals with TSC [34]. This evidence concerns the gene TSC2 and tuberous sclerosis.